Key Highlights

  • Jin Medical International (NASDAQ:ZJYL) traded at USD 3.06 after gains of 59.95% over one week and 55.87% over one month, although the latest session slipped 1.13% in published market data dated November 5, 2026.
  • Longer windows show 71.63% over three months and 44.59% over six months, yet the stock remains down 28.85% year to date, so the rally follows a deep slump rather than a steady climb.
  • The Huaxia Qiying acquisition, valued at USD 159.4 million, closed on September 24, 2026, with about 71.3 million Class A shares and 8.5 million advisory shares issued, roughly 79.8 million in total.
  • With about 158 million shares outstanding, USD 3.06 implies a calculated Market Value near USD 483 million, inside the USD 300 million to USD 2 billion small cap band.

Huaxia Qiying Deal Closing and the 17.33% After-Hours Jump

Jin Medical International (NASDAQ:ZJYL) reached USD 3.06 after a 59.95% weekly advance, a 55.87% monthly advance and a 1.13% decline in the latest session. Published coverage from October 30, 2026 put the shares at USD 2.1137 following a 17.33% after-hours gain tied to the Huaxia Qiying transaction, which leaves USD 3.06 a calculated 44.8% above that level. The USD 159.4 million deal closed on September 24, 2026. An 80% stake in Zhongjin Kangma Information Technology was due by October 31, 2026, and if it is not delivered, the company must issue 622,123 Class A shares instead.

No Single Weekly Catalyst, Only Small Business Fundamentals

No single catalyst for the weekly move was identified beyond the completed acquisition, so the points below are general context rather than explanation. Small Nasdaq names often re-rate when a transformational deal changes the narrative, when momentum traders find a depressed base or when a thin float meets sudden volume. The base was low, since the six-month gain of 44.59% still leaves the stock down 28.85% for the year. For the six months ended March 31, 2026, Revenue was USD 8.9 million, down 9.7%, gross Margin improved to 26.9% from 24.3%, and the net loss was USD 0.2 million.

Share Issuance, Thin Liquidity and Balance Sheet Limits

The share issuance matters greatly. In August 2026, published coverage cited a market Capitalization near USD 15.19 million at USD 1.94, a 52-week range of USD 1.64 to USD 17.18 and average Volume of 17,660 shares. With roughly 158 million shares now trading, the count has multiplied and existing holders were diluted. Cash stood at USD 9.1 million, alongside USD 21 million of short-term investments, at March 31, 2026. Spreads can be wide, few trades can shift the price and the move may reverse. No price to sales ratio appeared in the market data snapshot.

Where Things Stand

The best available explanation for the 59.95% weekly surge in Jin Medical International (NASDAQ:ZJYL) points to the closed USD 159.4 million acquisition, a low starting base and thin trading, with Earnings playing no visible role, since no single catalyst for the week was identified. The stock ranks on the small cap leaderboards for both one week and one month, with a 55.87% monthly gain. At USD 3.06 it is still down 28.85% year to date, and this article makes no forecast.